Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study

Hematol Transfus Cell Ther. 2020 Jan-Mar;42(1):90-92. doi: 10.1016/j.htct.2018.11.009. Epub 2019 Mar 28.
No abstract available

Publication types

  • Letter